Gender trend over time of principal investigators within large Australian cancer clinical trials groups

被引：0
|
作者：
Luong, T. T. V. [1 ]
Ho, C. H. [2 ]
Aedo-Lopez, V. [1 ]
Segelov, E. [1 ]
机构：
[1] Monash Hlth, Monash Canc Ctr, Oncol, Melbourne, Vic, Australia
[2] Monash Univ, Med, Clayton, Vic, Australia
来源：
ANNALS OF ONCOLOGY | 2022年 / 33卷
关键词：
D O I：
10.1016/j.annonc.2022.10.434
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
403P
引用
收藏
页码：S1600 / S1600
页数：1
相关论文
共 26 条
  • [21] Trends in progression-free survival (PFS) and time to progression (TTP) over time within first-line aromatase inhibitors trials in hormone receptor-positive advanced breast cancer
    T. Reinert
    M. Debiasi
    J. Bines
    C. H. Barrios
    Breast Cancer Research and Treatment, 2018, 168 : 457 - 465
  • [22] Abdominoperineal resection and not distance, gender or age associated with circumferential resection margin involvement in a pooled analysis of five large European randomised clinical trials on rectal cancer (n=5187)
    den Dulk, M.
    Putter, H.
    Collette, L.
    Marijnen, C. A. M.
    Pahlman, L.
    Bujko, K.
    Roedel, C. M.
    Bosset, J. F.
    van de Velde, C. J. H.
    EJC SUPPLEMENTS, 2007, 5 (04): : 237 - 237
  • [23] Dynamics of eligibility criteria for central nervous system metastases in non-small cell lung cancer randomized clinical trials over time: A systematic review
    Schoenmaekers, Janna Josephus Anna Oda
    Dursun, Safiye
    Biesmans, Charlotte
    Ruysscher, Dirk Karel Maria De
    Broen, Martinus Petrus Gertrudis
    Remon, Jordi
    Dingemans, Anne-Marie Clasina
    Hendriks, Lizza Elisabeth Lucia
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2021, 166
  • [24] Hazard rate of tumor recurrence over time in patients with colon cancer: implications for postoperative surveillance from three Japanese Foundation for Multi-disciplinary Treatment of Cancer (JFMC) clinical trials
    Maeda, Hiromichi
    Kashiwabara, Kosuke
    Aoyama, Toru
    Oba, Koji
    Honda, Michitaka
    Mayanagi, Shuhei
    Kanda, Mitsuro
    Hamada, Chikuma
    Sadahiro, Sotaro
    Sakamoto, Junichi
    Saji, Shigetoyo
    Yoshikawa, Takaki
    JOURNAL OF CANCER, 2017, 8 (19): : 4057 - 4064
  • [25] Changes over time in the course of advanced pancreatic cancer treatment with systemic chemotherapy: a pooled analysis of five clinical trials from two decades of the German AIO study group
    Weiss, L.
    Fischer, L. E.
    Heinemann, V.
    Gieseler, F.
    Hoehler, T.
    Mayerle, J.
    Quietzsch, D.
    Reinacher-Schick, A.
    Schenk, M.
    Seipelt, G.
    Siveke, J. T.
    Stahl, M.
    Kaiser, U.
    Waldschmidt, D. T.
    Dorman, K.
    Zhang, D.
    Westphalen, C. B.
    Boeck, S.
    Haas, M.
    ESMO OPEN, 2024, 9 (04)
  • [26] Original Research Minimally important differences for interpreting EORTC QLQ-C30 change scores over time: A synthesis across 21 clinical trials involving nine different cancer types
    Musoro, Jammbe Z.
    Coens, Corneel
    Sprangers, Mirjam A. G.
    Brandberg, Yvonne
    Groenvold, Mogens
    Flechtner, Hans-Henning
    Cocks, Kim
    Velikova, Galina
    Dirven, Linda
    Greimel, Elfriede
    Singer, Susanne
    Pogoda, Katarzyna
    Gamper, Eva M.
    Sodergren, Samantha C.
    Eggermont, Alexander
    Koller, Michael
    Reijneveld, Jaap C.
    Taphoorn, Martin J. B.
    King, Madeleine T.
    Bottomley, Andrew
    EUROPEAN JOURNAL OF CANCER, 2023, 188 : 171 - 182
123